Breaking News Instant updates and real-time market news.

WYNN

Wynn Resorts

$72.67 /

-1.63 (-2.19%)

, LVS

Las Vegas Sands

$45.72 /

-0.38 (-0.82%)

09:12
10/12/20
10/12
09:12
10/12/20
09:12

Wynn Resorts price target lowered to $115 from $120 at Barclays

Barclays analyst Felicia Hendrix lowered the firm's price target on Wynn Resorts (WYNN) to $115 from $120 and keeps an Overweight rating on the shares. With much investor focus on the "nascent and growing" sports betting opportunity, investors have lost sight of the "inevitable" turnaround in Macau, Hendrix tells investors in a research note. The analyst believes the Macau market is "closer to an inflection than it has been for some time." Las Vegas Sands (LVS) and Wynn Resorts are among the analyst's best ideas.

WYNN

Wynn Resorts

$72.67 /

-1.63 (-2.19%)

LVS

Las Vegas Sands

$45.72 /

-0.38 (-0.82%)

WYNN Wynn Resorts
$72.67 /

-1.63 (-2.19%)

10/05/20 Roth Capital
Macau numbers likely to go lower again, says Roth Capital
09/16/20 Roth Capital
Wynn Resorts downgraded to Neutral from Buy at Roth Capital
09/10/20 Deutsche Bank
Wynn Resorts price target raised to $97 from $89 at Deutsche Bank
09/09/20 JPMorgan
Wynn Resorts price target raised to $101 from $98 at JPMorgan
LVS Las Vegas Sands
$45.72 /

-0.38 (-0.82%)

09/16/20
Fly Intel: Top five analyst downgrades
09/16/20 Roth Capital
Las Vegas Sands downgraded to Neutral from Buy at Roth Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Mateon Therapeutics completes enrollment for OT-101 study » 07:22
03/08/21
03/08
07:22
03/08/21
07:22
MATN

Mateon Therapeutics

$0.00 /

+ (+0.00%)

Mateon Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MATN Mateon Therapeutics
$0.00 /

+ (+0.00%)

Upgrade
Mapletree Commercial Trust upgraded to Overweight from Neutral at JPMorgan » 07:22
03/08/21
03/08
07:22
03/08/21
07:22
MPCMF

Mapletree Commercial Trust

$0.00 /

+ (+0.00%)

JPMorgan analyst Mervin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MPCMF Mapletree Commercial Trust
$0.00 /

+ (+0.00%)

01/11/21 HSBC
Mapletree Commercial Trust downgraded to Hold from Buy at HSBC
Hot Stocks
Evolv Technology to be publicly traded through NewHold Investment Corp. merger » 07:21
03/08/21
03/08
07:21
03/08/21
07:21
NHIC

NewHold Investment Corp.

$10.00 /

+0.03 (+0.30%)

Evolv Technology and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NHIC NewHold Investment Corp.
$10.00 /

+0.03 (+0.30%)

NHIC NewHold Investment Corp.
$10.00 /

+0.03 (+0.30%)

Hot Stocks
Intersect ENT: CMS combines SINUVA sinus implant coverage under distinct code » 07:21
03/08/21
03/08
07:21
03/08/21
07:21
XENT

Intersect ENT

$23.77 /

+0.8 (+3.48%)

Intersect ENT announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XENT Intersect ENT
$23.77 /

+0.8 (+3.48%)

XENT Intersect ENT
$23.77 /

+0.8 (+3.48%)

01/15/21 Piper Sandler
Intersect ENT price target raised to $23 from $17 at Piper Sandler
01/11/21 Canaccord
Intersect ENT upgraded to Buy from Hold at Canaccord
11/19/20 BTIG
Intersect ENT upgraded to Buy from Neutral at BTIG
11/02/20 Piper Sandler
Intersect ENT price target raised to $17 from $16 at Piper Sandler
XENT Intersect ENT
$23.77 /

+0.8 (+3.48%)

Downgrade
Keppel DC REIT downgraded to Underweight from Overweight at JPMorgan » 07:21
03/08/21
03/08
07:21
03/08/21
07:21
KPDCF

Keppel DC REIT

$0.00 /

+ (+0.00%)

JPMorgan analyst Mervin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Athira Pharma appoints Barbara Kosacz to board of directors » 07:20
03/08/21
03/08
07:20
03/08/21
07:20
ATHA

Athira Pharma

$19.13 /

-0.13 (-0.67%)

, KRON

Kronos Bio

$28.01 /

-0.955 (-3.30%)

Athira Pharma (ATHA)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATHA Athira Pharma
$19.13 /

-0.13 (-0.67%)

KRON Kronos Bio
$28.01 /

-0.955 (-3.30%)

ATHA Athira Pharma
$19.13 /

-0.13 (-0.67%)

10/13/20 Jefferies
Athira Pharma initiated with a Buy at Jefferies
10/13/20 JMP Securities
Athira Pharma initiated with an Outperform at JMP Securities
10/13/20 Stifel
Athira Pharma initiated with a Buy at Stifel
10/13/20 Goldman Sachs
Athira Pharma initiated with a Buy at Goldman Sachs
KRON Kronos Bio
$28.01 /

-0.955 (-3.30%)

11/03/20
Fly Intel: Top five analyst initiations
11/03/20 Jefferies
Kronos Bio initiated with a Buy at Jefferies
11/03/20 Piper Sandler
Kronos Bio initiated with an Overweight at Piper Sandler
11/03/20 Goldman Sachs
Kronos Bio initiated with a Buy at Goldman Sachs
ATHA Athira Pharma
$19.13 /

-0.13 (-0.67%)

KRON Kronos Bio
$28.01 /

-0.955 (-3.30%)

  • 21
    Jan
  • 09
    Oct
  • 18
    Sep
ATHA Athira Pharma
$19.13 /

-0.13 (-0.67%)

KRON Kronos Bio
$28.01 /

-0.955 (-3.30%)

KRON Kronos Bio
$28.01 /

-0.955 (-3.30%)

Hot Stocks
Chemours announces project to reduce HFC-23 emissions at Kentucky site » 07:20
03/08/21
03/08
07:20
03/08/21
07:20
CC

Chemours

$27.43 /

+1.32 (+5.06%)

The Chemours Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CC Chemours
$27.43 /

+1.32 (+5.06%)

CC Chemours
$27.43 /

+1.32 (+5.06%)

02/17/21 Citi
Chemours price target raised to $29 from $27 at Citi
02/16/21 BMO Capital
Chemours price target raised to $38 from $33 at BMO Capital
01/08/21 RBC Capital
Chemours upgraded to Outperform from Sector Perform at RBC Capital
12/04/20 Barclays
Chemours downgraded to Equal Weight ahead of PFAS news flow at Barclays
CC Chemours
$27.43 /

+1.32 (+5.06%)

CC Chemours
$27.43 /

+1.32 (+5.06%)

CC Chemours
$27.43 /

+1.32 (+5.06%)

Downgrade
Frasers Centrepoint Trust downgraded to Neutral from Overweight at JPMorgan » 07:20
03/08/21
03/08
07:20
03/08/21
07:20
FRZCF

Frasers Centrepoint Trust

$0.00 /

+ (+0.00%)

JPMorgan analyst Mervin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRZCF Frasers Centrepoint Trust
$0.00 /

+ (+0.00%)

05/21/20 JPMorgan
Frasers Centrepoint Trust upgraded to Overweight from Neutral at JPMorgan
Earnings
United Bancshares reports 2020 EPS $4.21, up 95c vs. last year » 07:19
03/08/21
03/08
07:19
03/08/21
07:19
UBOH

United Bancshares

$23.60 /

+ (+0.00%)

Return on average total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Gap price target raised to $31 from $26 at Deutsche Bank » 07:18
03/08/21
03/08
07:18
03/08/21
07:18
GPS

Gap

$27.30 /

+1.87 (+7.35%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GPS Gap
$27.30 /

+1.87 (+7.35%)

GPS Gap
$27.30 /

+1.87 (+7.35%)

03/05/21 B. Riley Securities
Gap price target raised to $27 from $22 at B. Riley Securities
03/05/21 JPMorgan
Gap price target raised to $32 from $30 at JPMorgan
03/05/21 Morgan Stanley
Gap price target raised to $29 from $27 at Morgan Stanley
03/05/21 Baird
Gap price target raised to $29 from $25 at Baird
GPS Gap
$27.30 /

+1.87 (+7.35%)

GPS Gap
$27.30 /

+1.87 (+7.35%)

GPS Gap
$27.30 /

+1.87 (+7.35%)

GPS Gap
$27.30 /

+1.87 (+7.35%)

Initiation
Adagene initiated with an Overweight at Morgan Stanley » 07:18
03/08/21
03/08
07:18
03/08/21
07:18
ADAG

Adagene

$23.05 /

+0.39 (+1.72%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADAG Adagene
$23.05 /

+0.39 (+1.72%)

03/06/21 Goldman Sachs
Adagene initiated with a Buy at Goldman Sachs
  • 09
    Feb
ADAG Adagene
$23.05 /

+0.39 (+1.72%)

Recommendations
Playa show see cash flow inflection no later than Q4, says Deutsche Bank » 07:18
03/08/21
03/08
07:18
03/08/21
07:18
PLYA

Playa Hotels & Resorts

$6.85 /

-0.05 (-0.72%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLYA Playa Hotels & Resorts
$6.85 /

-0.05 (-0.72%)

PLYA Playa Hotels & Resorts
$6.85 /

-0.05 (-0.72%)

01/11/21 Macquarie
Playa Hotels & Resorts price target raised to $8 from $7 at Macquarie
12/15/20 Citi
Playa Hotels & Resorts upgraded to Neutral from Sell at Citi
07/02/20 Citi
Playa Hotels & Resorts price target raised to $3 from $1 at Citi
04/29/20 SunTrust
Playa Hotels & Resorts downgraded to Hold from Buy at SunTrust
PLYA Playa Hotels & Resorts
$6.85 /

-0.05 (-0.72%)

  • 07
    Jan
  • 19
    Nov
PLYA Playa Hotels & Resorts
$6.85 /

-0.05 (-0.72%)

Hot Stocks
Passage Bio to start PBFT02 clinical program in 1H21 » 07:18
03/08/21
03/08
07:18
03/08/21
07:18
PASG

Passage Bio

$19.83 /

+0.44 (+2.27%)

Passage Bio is advancing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

05:06 Today Chardan
Passage Bio price target raised to $45 from $35 at Chardan
03/04/21 Citi
Citi remains buyer of Passage Bio into first clinical data
03/04/21 Goldman Sachs
Passage Bio upgraded to Buy from Neutral at Goldman Sachs
02/04/21
Fly Intel: Top five analyst initiations
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

  • 22
    Jan
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

Hot Stocks
Passage Bio to start Phase 1/2 trial of PBKR03 in 1H21 » 07:17
03/08/21
03/08
07:17
03/08/21
07:17
PASG

Passage Bio

$19.83 /

+0.44 (+2.27%)

Passage Bio is developing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

05:06 Today Chardan
Passage Bio price target raised to $45 from $35 at Chardan
03/04/21 Citi
Citi remains buyer of Passage Bio into first clinical data
03/04/21 Goldman Sachs
Passage Bio upgraded to Buy from Neutral at Goldman Sachs
02/04/21
Fly Intel: Top five analyst initiations
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

  • 22
    Jan
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

Hot Stocks
Passage Bio to dose first patient in global Imagine-1 study in Q1 » 07:16
03/08/21
03/08
07:16
03/08/21
07:16
PASG

Passage Bio

$19.83 /

+0.44 (+2.27%)

PBGM01 is being studied…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

05:06 Today Chardan
Passage Bio price target raised to $45 from $35 at Chardan
03/04/21 Citi
Citi remains buyer of Passage Bio into first clinical data
03/04/21 Goldman Sachs
Passage Bio upgraded to Buy from Neutral at Goldman Sachs
02/04/21
Fly Intel: Top five analyst initiations
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

  • 22
    Jan
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

Hot Stocks
Passage Bio receives Fast Track designations for PBGM01, PBFT02, PBKR03 » 07:15
03/08/21
03/08
07:15
03/08/21
07:15
PASG

Passage Bio

$19.83 /

+0.44 (+2.27%)

Passage Bio announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

05:06 Today Chardan
Passage Bio price target raised to $45 from $35 at Chardan
03/04/21 Citi
Citi remains buyer of Passage Bio into first clinical data
03/04/21 Goldman Sachs
Passage Bio upgraded to Buy from Neutral at Goldman Sachs
02/04/21
Fly Intel: Top five analyst initiations
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

  • 22
    Jan
PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

PASG Passage Bio
$19.83 /

+0.44 (+2.27%)

Hot Stocks
Victory Capital announces Alderwood secures FCA authorization » 07:15
03/08/21
03/08
07:15
03/08/21
07:15
VCTR

Victory Capital

$24.55 /

+0.94 (+3.98%)

Victory Capital reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VCTR Victory Capital
$24.55 /

+0.94 (+3.98%)

VCTR Victory Capital
$24.55 /

+0.94 (+3.98%)

11/19/20
Fly Intel: Top five analyst downgrades
11/19/20 BofA
Victory Capital double-downgraded to Underperform from Buy at BofA
10/16/20 B. Riley Securities
Victory Capital price target raised to $24 from $22 at B. Riley Securities
07/09/20 Barclays
Victory Capital price target raised to $21 from $19 at Barclays
VCTR Victory Capital
$24.55 /

+0.94 (+3.98%)

VCTR Victory Capital
$24.55 /

+0.94 (+3.98%)

Recommendations
Western Digital price target raised to $80 from $65 at Deutsche Bank » 07:14
03/08/21
03/08
07:14
03/08/21
07:14
WDC

Western Digital

$68.09 /

+4.61 (+7.26%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDC Western Digital
$68.09 /

+4.61 (+7.26%)

WDC Western Digital
$68.09 /

+4.61 (+7.26%)

03/04/21 Goldman Sachs
Western Digital upgraded to Buy from Neutral at Goldman Sachs
03/01/21 Barclays
Western Digital price target raised to $75 from $53 at Barclays
02/25/21 Mizuho
Western Digital price target raised to $80 from $65 at Mizuho
02/24/21 Benchmark
Benchmark says Biden order bodes well for Nova Measuring, other semi suppliers
WDC Western Digital
$68.09 /

+4.61 (+7.26%)

WDC Western Digital
$68.09 /

+4.61 (+7.26%)

WDC Western Digital
$68.09 /

+4.61 (+7.26%)

WDC Western Digital
$68.09 /

+4.61 (+7.26%)

Hot Stocks
Mesa Air reports 20,457 block hours in February » 07:14
03/08/21
03/08
07:14
03/08/21
07:14
MESA

Mesa Air

$12.58 /

-0.39 (-3.01%)

Mesa Air Group reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MESA Mesa Air
$12.58 /

-0.39 (-3.01%)

MESA Mesa Air
$12.58 /

-0.39 (-3.01%)

03/04/21
Fly Intel: Top five analyst downgrades
03/04/21 Deutsche Bank
Mesa Air downgraded to Hold after 100% rally at Deutsche Bank
03/03/21 Deutsche Bank
Mesa Air downgraded to Hold from Buy at Deutsche Bank
02/17/21
Fly Intel: Top five analyst upgrades
MESA Mesa Air
$12.58 /

-0.39 (-3.01%)

MESA Mesa Air
$12.58 /

-0.39 (-3.01%)

MESA Mesa Air
$12.58 /

-0.39 (-3.01%)

Hot Stocks
McAfee to sell enterprise business to STG-led consortium for $4B in cash » 07:14
03/08/21
03/08
07:14
03/08/21
07:14
MCFE

McAfee

$21.22 /

-0.09 (-0.42%)

McAfee announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCFE McAfee
$21.22 /

-0.09 (-0.42%)

MCFE McAfee
$21.22 /

-0.09 (-0.42%)

02/24/21 Deutsche Bank
Deutsche upgrades McAfee on 'best-in-class' consumer security unit
02/24/21 Mizuho
McAfee price target raised to $26 from $25 at Mizuho
02/24/21 Citi
McAfee price target raised to $21 from $18 at Citi
02/24/21 Deutsche Bank
McAfee upgraded to Buy from Hold at Deutsche Bank
MCFE McAfee
$21.22 /

-0.09 (-0.42%)

  • 22
    Oct
MCFE McAfee
$21.22 /

-0.09 (-0.42%)

MCFE McAfee
$21.22 /

-0.09 (-0.42%)

Hot Stocks
Harbor Custom Development acquires 48 acres in Washington for $3.9M » 07:13
03/08/21
03/08
07:13
03/08/21
07:13
HCDI

Harbor Custom Development

$2.96 /

+0.01 (+0.34%)

Harbor Custom Development…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCDI Harbor Custom Development
$2.96 /

+0.01 (+0.34%)

HCDI Harbor Custom Development
$2.96 /

+0.01 (+0.34%)

  • 13
    Jan
  • 07
    Aug
HCDI Harbor Custom Development
$2.96 /

+0.01 (+0.34%)

Upgrade
Waitr Holdings upgraded to Buy from Hold at Deutsche Bank » 07:13
03/08/21
03/08
07:13
03/08/21
07:13
WTRH

Waitr Holdings

$3.20 /

+0.205 (+6.86%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTRH Waitr Holdings
$3.20 /

+0.205 (+6.86%)

WTRH Waitr Holdings
$3.20 /

+0.205 (+6.86%)

05:58 Today Deutsche Bank
Waitr Holdings upgraded to Buy from Hold at Deutsche Bank
03/05/21 B. Riley Securities
Waitr share price offers opportunity ahead of results, says B. Riley
11/10/20 B. Riley Securities
Waitr Holdings price target lowered to $7 from $8 at B. Riley Securities
07/22/20 B. Riley FBR
B. Riley FBR starts Waitr at Buy, calls attractive takeout candidate
WTRH Waitr Holdings
$3.20 /

+0.205 (+6.86%)

WTRH Waitr Holdings
$3.20 /

+0.205 (+6.86%)

Hot Stocks
Baudax Bio appoints Richard Casten as CFO » 07:12
03/08/21
03/08
07:12
03/08/21
07:12
BXRX

Baudax Bio

$1.22 /

+0.025 (+2.09%)

, REPH

Recro Pharma

$3.28 /

-0.365 (-10.03%)

Baudax Bio (BXRX)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BXRX Baudax Bio
$1.22 /

+0.025 (+2.09%)

REPH Recro Pharma
$3.28 /

-0.365 (-10.03%)

BXRX Baudax Bio
$1.22 /

+0.025 (+2.09%)

05/15/20 JMP Securities
Baudax Bio initiated with an Outperform at JMP Securities
REPH Recro Pharma
$3.28 /

-0.365 (-10.03%)

01/04/21 Craig-Hallum
Recro Pharma initiated with a Buy at Craig-Hallum
05/12/20 Oppenheimer
Recro Pharma price target lowered to $12 from $18 at Oppenheimer
BXRX Baudax Bio
$1.22 /

+0.025 (+2.09%)

REPH Recro Pharma
$3.28 /

-0.365 (-10.03%)

  • 24
    Mar
Hot Stocks
Eventbrite provides February operating update » 07:12
03/08/21
03/08
07:12
03/08/21
07:12
EB

Eventbrite

$22.73 /

-0.12 (-0.53%)

Eventbrite provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EB Eventbrite
$22.73 /

-0.12 (-0.53%)

EB Eventbrite
$22.73 /

-0.12 (-0.53%)

12/16/20 JPMorgan
Eventbrite price target raised to $15 from $10 at JPMorgan
05/18/20
Fly Intel: Top five analyst upgrades
05/18/20 SunTrust
Eventbrite upgraded to Buy at SunTrust on valuation
05/18/20 SunTrust
Eventbrite upgraded to Buy from Hold at SunTrust
EB Eventbrite
$22.73 /

-0.12 (-0.53%)

EB Eventbrite
$22.73 /

-0.12 (-0.53%)

Hot Stocks
Terns to report data from Phase 2a LIFT study of TERN-101 in 3Q21 » 07:10
03/08/21
03/08
07:10
03/08/21
07:10
TERN

Terns Pharmaceuticals

$17.13 /

-1.81 (-9.56%)

Terns Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TERN Terns Pharmaceuticals
$17.13 /

-1.81 (-9.56%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
  • 05
    Feb
TERN Terns Pharmaceuticals
$17.13 /

-1.81 (-9.56%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.